MP-0621

N/A

Report date: 2024/06/28 16:56:13

Base Information

Drug NameMP-0621

Drug Alias NameMP-0621MP0621

ClassificationBiologics

Mechanisms of ActionLow affinity immunoglobulin gamma Fc region receptor III-A modulatorsCluster of differentiation 47 modulatorsStem cell growth factor receptor activators

TargetsLow affinity immunoglobulin gamma Fc region receptor III-ACluster of differentiation 47Stem cell growth factor receptor

Therapy Area/IndicationsLeukemia, Myeloid, AcuteHematopoietic stem cell transplantation (HSCT)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMolecular Partners Ag

China Registration ClassN/A

Develop Information

Active CompaniesMolecular Partners Ag

Inactive CompaniesN/A

Active IndicationsLeukemia, Myeloid, AcuteHematopoietic stem cell transplantation (HSCT)

Inactive IndicationsN/A

Other Information

ATC CodeN/A